Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Negative results of an Italian Group for Mesothelioma (G.I.Me.) pilot study of single-agent imatinib mesylate in malignant pleural mesothelioma.

× No keyword cloud information.

19 in total

Review 1. Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma.

Authors: Roberto E Favoni; Antonio Daga; Paolo Malatesta; Tullio Florio
Journal: Br J Pharmacol Date: 2012-05 Impact factor: 8.739

Review 2. Novel systemic therapy against malignant pleural mesothelioma.

Authors: Michael R Mancuso; Joel W Neal
Journal: Transl Lung Cancer Res Date: 2017-06

3. A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance).

Authors: Kaushal Parikh; Sumithra J Mandrekar; Katie Allen-Ziegler; Brandt Esplin; Angelina D Tan; Benjamin Marchello; Alex A Adjei; Julian R Molina
Journal: Oncologist Date: 2019-12-24

4. Pleural mesothelioma instigates tumor-associated fibroblasts to promote progression via a malignant cytokine network.

Authors: Qi Li; Wei Wang; Tadaaki Yamada; Kunio Matsumoto; Katsuya Sakai; Yoshimi Bando; Hisanori Uehara; Yasuhiko Nishioka; Saburo Sone; Shotaro Iwakiri; Kazumi Itoi; Teruhiro Utsugi; Kazuo Yasumoto; Seiji Yano
Journal: Am J Pathol Date: 2011-07-18 Impact factor: 4.307

Review 5. Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies.

Authors: Andrew R Haas; Daniel H Sterman
Journal: Clin Chest Med Date: 2013-01-17 Impact factor: 2.878

Review 6. Chemotherapy and targeted therapies for unresectable malignant mesothelioma.

Authors: Ronan Joseph Kelly; Elad Sharon; Raffit Hassan
Journal: Lung Cancer Date: 2011-05-28 Impact factor: 5.705

Review 7. Target therapy: new drugs or new combinations of drugs in malignant pleural mesothelioma.

Authors: Paolo A Zucali
Journal: J Thorac Dis Date: 2018-01 Impact factor: 2.895

Review 8. Malignant Pleural Mesothelioma: Is Tailoring the Second-Line Therapy Really "Raising the Bar?"

Authors: Vincenzo Di Noia; Emanuele Vita; Miriam Ferrara; Antonia Strippoli; Michele Basso; Giovanni Schinzari; Alessandra Cassano; Emilio Bria; Carlo Barone; Ettore D'Argento
Journal: Curr Treat Options Oncol Date: 2019-02-21

Review 9. Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies.

Authors: Angela Bononi; Andrea Napolitano; Harvey I Pass; Haining Yang; Michele Carbone
Journal: Expert Rev Respir Med Date: 2015-08-26 Impact factor: 3.772

10. Phase I trial of cisplatin, pemetrexed, and imatinib mesylate in chemonaive patients with unresectable malignant pleural mesothelioma.

Authors: Anne S Tsao; Nusrat Harun; J Jack Lee; John Heymach; Katherine Pisters; Waun Ki Hong; Junya Fujimoto; Ignacio Wistuba
Journal: Clin Lung Cancer Date: 2013-12-27 Impact factor: 4.785